Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: A phase 3, randomized, active-controlled, multicenter, non-inferiority trial (WIN-IND study)
Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: A phase 3, randomized, active-controlled, multicenter, non-inferiority trial (WIN-IND study). // Metabolism Open. – URL: https://www.sciencedirect.com/science/article/pii/S2589936826000484?dgcid=rss_sd_all
Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: A phase 3, randomized, active-controlled, multicenter, non-inferiority trial (WIN-IND study). Metabolism Open. https://www.sciencedirect.com/science/article/pii/S2589936826000484?dgcid=rss_sd_all
“Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: A phase 3, randomized, active-controlled, multicenter, non-inferiority trial (WIN-IND study).” Metabolism Open.
@article{article58802,
title = {Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: A phase 3, randomized, active-controlled, multicenter, non-inferiority trial (WIN-IND study)},
journal = {Metabolism Open},
url = {https://www.sciencedirect.com/science/article/pii/S2589936826000484?dgcid=rss_sd_all}
}